Skip to main content
190 results

As healthcare professionals, we face the dual challenge of providing high-quality care while also minimising our environmental footprint.

The NHS is under increased financial and environmental pressures. Blanket switching of medications (changing medication from one to another without patient consultation) to more cost-effective and environmentally friendly options is therefore becoming more common. 

Aimed at primary care respiratory leaders, this blueprint document provides 10 tips for contacting your local MP about environmental issues.

The COPD risk slider is a tool which can be easily used by primary care healthcare professionals in their normal 10-20 minute consultation to assess exacerbation risk in their COPD patients. It will support healthcare professionals and pharmacists to:

Maintenance and reliever therapy (MART) is a combined treatment system for asthma where a single, combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.

In this article, the authors review evidence, guidance and current practice to provide a consensus approach to calculating and interpreting peak expiratory flow rate (PEFR) variability and reversibility from peak flow diary recordings for asthma diagnosis.

In 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved the use of a dual (Inhaled corticosteroid/ Formoterol) combination treatment to be used as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an a

NICE Diagnostic Guidance 12 (DG12); Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath.

NICE guidance is integral to the clinical care that we offer as Health Care Professionals (HCPs).

accuRx has created a FeNO template to send to patients prior to their appointment via text message. For information on what's included and how to find the template, have a look at the guidance document below.

These templates are only available to EMIS and TPP users – they are not available to MicroTest and Vision users.

The AHSN Network supported the spread of FeNO testing across primary care in England from April 2021 to March 2023, led by Wessex AHSN as the lead AHSN. This programme was delivered as part of the NHS England Accelerated Access Collaborative Rapid Uptake Programme.

The one-minute sit to stand test (1-MSTST) has become the test of choice during the pandemic for measuring exercise capacity, both at in-person and virtual appointments due to the inability to conduct robust six minute or incremental / endurance shuttle walk tests (6MWT/ ISWT/ ESWT).